CPVT is typically caused by mutations in genes associated with calcium regulation in cardiac cells, such as the ryanodine receptor gene (RyR2) and calsequestrin gene (CASQ2). This evidence concerns the gene CASQ2 and catecholaminergic polymorphic ventricular tachycardia.